Clinical trials
Phase 1 Post-Acute COVID-19 Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Completed | 3 |
| Terminated | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hackensack Meridian Health | 2 |
| Charles Cox | 1 |
| Johns Hopkins University | 1 |
| Jonathann Kuo, MD | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| State University of New York at Buffalo | 1 |
| Stephanie B. Seminara, MD | 1 |
| University of California, Davis | 1 |
| University of California, Irvine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Post-Acute COVID-19 Syndrome | 12 |
| COVID-19 | 5 |
| Autonomic Nervous System Diseases | 1 |
| Dyspnea | 1 |
| Inflammation | 1 |
| Multiple Sclerosis | 1 |
| Nerve Degeneration | 1 |
| Obesity | 1 |
| Obesity, Morbid | 1 |
| Shy-Drager Syndrome | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.